To determine that FGF-2 ligand enhances osteoblast differentiation and osteogenic capacity in cultured GCT stromal cells through FGFR-2IIIc signaling, FGFR-2IIIc expression was knocked down by transient transfection of siRNA in GCT stromal cells. This evidence concerns the gene FGF2 and granular cell tumor.